{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:57:26Z","timestamp":1790773046956,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05216-1","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:14:25Z","timestamp":1785291265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of anrikefon in the treatment of diabetic hemodialysis patients with pruritus: a post hoc analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Zuo-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"5216_CR1","doi-asserted-by":"publisher","unstructured":"Yosipovitch G. Chronic kidney disease\u2013associated pruritus, still a vexing problem. NEJM Evidence. 2023;2(11):EVIDe2300227. https:\/\/doi.org\/10.1056\/EVIDe2300227.","DOI":"10.1056\/EVIDe2300227"},{"issue":"6","key":"5216_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/j.ajkd.2023.04.008","volume":"82","author":"N Sukul","year":"2023","unstructured":"Sukul N, Zhao J, Pisoni RL, Walpen S, Schaufler T, Asgari E, et al. Pruritus in hemodialysis patients: longitudinal associations with clinical and patient-reported outcomes. Am J Kidney Dis. 2023;82(6):666\u201376. https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.008.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"5216_CR3","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2215\/CJN.0000000000000537","volume":"19","author":"KK Tennankore","year":"2024","unstructured":"Tennankore KK, McCullough K, Bieber B, Cho Y, Johnson DW, Kanjanabuch T, et al. Prevalence and outcomes of chronic kidney disease-associated pruritus: international results from peritoneal dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2024;19(12):1622\u201334. https:\/\/doi.org\/10.2215\/CJN.0000000000000537.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5216_CR4","doi-asserted-by":"publisher","first-page":"1640144","DOI":"10.3389\/fmed.2025.1640144","volume":"12","author":"N Dorf","year":"2025","unstructured":"Dorf N, Maciejczyk M. Skin manifestations in diabetes\u2014What is new? Front Med. 2025;12:1640144. https:\/\/doi.org\/10.3389\/fmed.2025.1640144.","journal-title":"Front Med"},{"issue":"1","key":"5216_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-016-0176-y","volume":"8","author":"DM Gm","year":"2016","unstructured":"Gm DM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr. 2016;8(1):63.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"5216_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12902-025-02120-x","volume":"26","author":"X Cai","year":"2026","unstructured":"Cai X, Tang J, Yan J, Shi L, Xu Y, Tu Y. Analysis of correlated factors of skin pruritus in type 2 diabetes mellitus. BMC Endocr Disord. 2026;26(1):51. https:\/\/doi.org\/10.1186\/s12902-025-02120-x.","journal-title":"BMC Endocr Disord"},{"key":"5216_CR7","doi-asserted-by":"publisher","first-page":"842884","DOI":"10.3389\/fsurg.2022.842884","volume":"9","author":"QP Yang","year":"2022","unstructured":"Yang QP, Chen YY, Li Z, Xu M. Major risk factors analysis of pruritus complicated by type 2 diabetes mellitus and the effect of comprehensive nursing intervention. Front Surg. 2022;9:842884. https:\/\/doi.org\/10.3389\/fsurg.2022.842884.","journal-title":"Front Surg"},{"issue":"1","key":"5216_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.ajkd.2024.05.013","volume":"85","author":"AL Faucon","year":"2025","unstructured":"Faucon AL, Clase CM, Rydell H, Uhde M, Barany P, Evans M, et al. Burden of CKD-associated pruritus and adverse clinical outcomes in patients receiving dialysis: the stockholm creatinine measurements (SCREAM) project. Am J Kidney Dis. 2025;85(1):45\u201354.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2024.05.013.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5216_CR9","doi-asserted-by":"publisher","first-page":"100754","DOI":"10.1016\/j.xkme.2023.100754","volume":"6","author":"JS Scherer","year":"2024","unstructured":"Scherer JS, Tu C, Pisoni RL, Speyer E, Lopes AA, Wen W, et al. Ckdopps investigators. CKD-associated pruritus and clinical outcomes in nondialysis CKD. Kidney Med. 2024;6(1):100754. https:\/\/doi.org\/10.1016\/j.xkme.2023.100754.","journal-title":"Kidney Med"},{"issue":"9","key":"5216_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ekir.2020.04.027","volume":"5","author":"HA Verduzco","year":"2020","unstructured":"Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management. Kidney Int Rep. 2020;5(9):1387\u2013402. https:\/\/doi.org\/10.1016\/j.ekir.2020.04.027.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"5216_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/toxins13080527","volume":"13","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic kidney disease-associated pruritus. Toxins (Basel). 2021;13(8):527. https:\/\/doi.org\/10.3390\/toxins13080527.","journal-title":"Toxins (Basel)"},{"issue":"5","key":"5216_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.09600818","volume":"14","author":"N Sukul","year":"2019","unstructured":"Sukul N, Speyer E, Tu C, Bieber BA, Li Y, Lopes AA, et al. Ckdopps and CKD-REIN investigators. Pruritus and patient reported outcomes in non-dialysis CKD. Clin J Am Soc Nephrol. 2019;14(5):673\u201381. https:\/\/doi.org\/10.2215\/CJN.09600818.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"5216_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2215\/CJN.09480822","volume":"18","author":"KE Wulczyn","year":"2023","unstructured":"Wulczyn KE, Rhee EP, Myint L, Kalim S, Shafi T. Incidence and risk factors for pruritus in patients with nondialysis CKD. Clin J Am Soc Nephrol. 2023;18(2):193\u2013203. https:\/\/doi.org\/10.2215\/CJN.09480822.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5216_CR14","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1038\/s41467-025-60013-y","volume":"16","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Xu Y, Lei Q, Yang M, Wang S, Hu X, et al. HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials. Nat Commun. 2025;16(1):4830. https:\/\/doi.org\/10.1038\/s41467-025-60013-y.","journal-title":"Nat Commun"},{"key":"5216_CR15","doi-asserted-by":"publisher","first-page":"1583515","DOI":"10.3389\/fphar.2025.1583515","volume":"16","author":"MM Pan","year":"2025","unstructured":"Pan MM, Gao M, Zhou L, Xu Y, Yao L, Wu CQ, et al. Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial. Front Pharmacol. 2025;16:1583515. https:\/\/doi.org\/10.3389\/fphar.2025.1583515.","journal-title":"Front Pharmacol"},{"key":"5216_CR16","doi-asserted-by":"publisher","unstructured":"Liu BC, Li ZL, Zhang P, Zhong AM, Bai YL, Xu Y, et al. Anrikefon-302 study collaborator group. Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial. BMJ. 2025;390:e085208. https:\/\/doi.org\/10.1136\/bmj-2025-085208.","DOI":"10.1136\/bmj-2025-085208"},{"issue":"10518","key":"5216_CR17","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","volume":"406","author":"PB Mark","year":"2025","unstructured":"Mark PB, Stafford LK, Grams ME, Aalruz H, Abd ElHafeez S, Abdelgalil AA, et al. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023. Lancet. 2025;406(10518):2461\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(25)01853-7.","journal-title":"Lancet"},{"issue":"2","key":"5216_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5114\/ada.2019.89712","volume":"38","author":"AA Stefaniak","year":"2021","unstructured":"Stefaniak AA, Chlebicka I, Szepietowski JC. Itch in diabetes: a common underestimated problem. Postepy Dermatol Alergol. 2021;38(2):177\u201383. https:\/\/doi.org\/10.5114\/ada.2019.89712.","journal-title":"Postepy Dermatol Alergol"},{"issue":"5","key":"5216_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1684\/ejd.2013.2100","volume":"23","author":"MJ Ko","year":"2013","unstructured":"Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol. 2013;23(5):688\u201393. https:\/\/doi.org\/10.1684\/ejd.2013.2100.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"5216_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1468-3083.2008.02950.x","volume":"23","author":"H Seirafi","year":"2009","unstructured":"Seirafi H, Farsinejad K, Firooz A, Davoudi SM, Robati RM, Hoseini MS, et al. Biophysical characteristics of skin in diabetes: a controlled study. J Eur Acad Dermatol Venereol. 2009;23(2):146\u201349. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02950.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"5216_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/ajd.14092","volume":"64","author":"PB La","year":"2023","unstructured":"La PB, Fortier J, Almeda-Valdes P, Dc GO, Mena-Hern\u00e1ndez L, Ml\u00e1 C-H, et al. Multifactorial causes of chronic itch in diabetes: more than just neuropathy. Aust J Dermatol. 2023;64(3):354\u201358. https:\/\/doi.org\/10.1111\/ajd.14092.","journal-title":"Aust J Dermatol"},{"issue":"7","key":"5216_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","volume":"17","author":"G Sloan","year":"2021","unstructured":"Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400\u201320. https:\/\/doi.org\/10.1038\/s41574-021-00496-z.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"5216_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mus.27014","volume":"63","author":"K Patel","year":"2021","unstructured":"Patel K, Horak H, Tiryaki E. Diabetic neuropathies. Muscle Nerve. 2021;63(1):22\u201330. https:\/\/doi.org\/10.1002\/mus.27014.","journal-title":"Muscle Nerve"},{"key":"5216_CR24","doi-asserted-by":"publisher","unstructured":"Latus J, Lanot A, St\u00e4nder S, Sanchez-Alvarez E, Aucella F, Yosipovitch G. CKD-associated pruritus in haemodialysis: a road map for diagnosis and treatment. Clin Kidney J. 2025;18(5):sfaf096. https:\/\/doi.org\/10.1093\/ckj\/sfaf096.","DOI":"10.1093\/ckj\/sfaf096"},{"issue":"12","key":"5216_CR25","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","volume":"19","author":"AI Gunal","year":"2004","unstructured":"Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transpl. 2004;19(12):3137\u201339. https:\/\/doi.org\/10.1093\/ndt\/gfh496.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"5216_CR26","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.xkme.2026.101341","volume":"8","author":"C Rigatto","year":"2026","unstructured":"Rigatto C, Lu T, Schaufler T, Ruessmann D, Pisoni RL, Bieber B, et al. Gabapentin utilization and adverse effects among US hemodialysis patients diagnosed with pruritus or neuropathic pain. Kidney Med. 2026;8(5):101341. https:\/\/doi.org\/10.1016\/j.xkme.2026.101341.","journal-title":"Kidney Med"},{"key":"5216_CR27","doi-asserted-by":"publisher","first-page":"773204","DOI":"10.3389\/fphar.2021.773204","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Gou X, Yu X, Bai D, Tan B, Cao P, et al. Antinociceptive and antipruritic effects of HSK21542, a peripherally-restricted kappa opioid receptor agonist, in animal models of pain and itch. Front Pharmacol. 2021;12:773204. https:\/\/doi.org\/10.3389\/fphar.2021.773204.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5216_CR28","doi-asserted-by":"publisher","first-page":"5164503","DOI":"10.1155\/jdr\/5164503","volume":"2025","author":"G Liu","year":"2025","unstructured":"Liu G, Li T, Chen C, Xiao N. Health-related quality of life and psychosocial outcomes in patients with type 2 diabetes mellitus: a bibliometric analysis. J Diabetes Res. 2025;2025(1):5164503. https:\/\/doi.org\/10.1155\/jdr\/5164503.","journal-title":"J Diabetes Res"},{"issue":"7","key":"5216_CR29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc18-1256","volume":"42","author":"BA Bruno","year":"2019","unstructured":"Bruno BA, Choi D, Thorpe KE, Yu CH. Relationship among diabetes distress, decisional conflict, quality of life, and patient perception of chronic illness care in a cohort of patients with type 2 diabetes and other comorbidities. Diabetes Care. 2019;42(7):1170\u201377. https:\/\/doi.org\/10.2337\/dc18-1256.","journal-title":"Diabetes Care"},{"issue":"24","key":"5216_CR30","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.2024.4899","volume":"331","author":"DC Butler","year":"2024","unstructured":"Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, et al. Chronic pruritus: a review. JAMA. 2024;331(24):2114\u201324. https:\/\/doi.org\/10.1001\/jama.2024.4899.","journal-title":"JAMA"},{"key":"5216_CR31","doi-asserted-by":"publisher","unstructured":"David P, Singh S, Ankar R. A comprehensive overview of skin complications in diabetes and their prevention. Cureus. 2023;15(5):e38961. https:\/\/doi.org\/10.7759\/cureus.38961.","DOI":"10.7759\/cureus.38961"},{"issue":"1","key":"5216_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/clinpract12010004","volume":"12","author":"S Kalra","year":"2022","unstructured":"Kalra S, Mittal A, Rathod RM, Pinto C, Rathod R, Mane A. Knowledge, attitude and practice for pruritus management in physicians and patients with diabetes. Clinics Pract. 2022;12(1):27\u201336. https:\/\/doi.org\/10.3390\/clinpract12010004.","journal-title":"Clinics Pract"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05216-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:01:57Z","timestamp":1790769717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05216-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5216"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05216-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a\n                      post hoc\n                      analysis of data collected in a randomized, placebo-controlled phase 3 study, which was conducted in accordance with the principles of the Declaration of Helsinki. Institutional review boards or independent ethics committees reviewed and approved the protocols before studies were commenced (the ethics committee of the Clinical Research of the First Affiliated Hospital to Zhejiang University School of Medicine [approval No 2022\u2013177], Zhongda Hospital Affiliated to Southeast University School of Medicine [approval No 2021ZDSYLL318-Y01], and all other participating centers). Informed consent was obtained from each patient.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"576"}}